HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vladimir P Chekhonin Selected Research

Monoclonal Antibodies

5/2015Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1.
5/2015VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor.
1/2012Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43.
7/2011Visualization of Connexin 43-positive cells of glioma and the periglioma zone by means of intravenously injected monoclonal antibodies.
3/2009Targeted transport of 125I-labeled antibody to GFAP and AMVB1 in an experimental rat model of C6 glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vladimir P Chekhonin Research Topics

Disease

28Neoplasms (Cancer)
01/2024 - 03/2009
17Glioma (Gliomas)
01/2024 - 03/2009
8Glioblastoma (Glioblastoma Multiforme)
01/2024 - 03/2009
5Neoplasm Metastasis (Metastasis)
08/2023 - 07/2019
5Infections
12/2022 - 01/2018
4Breast Neoplasms (Breast Cancer)
03/2023 - 05/2013
4Brain Neoplasms (Brain Tumor)
11/2016 - 06/2012
3Inflammation (Inflammations)
11/2023 - 05/2016
3Stroke (Strokes)
01/2023 - 01/2021
3Spinal Cord Injuries (Spinal Cord Injury)
05/2021 - 01/2016
2Lymphopenia (Lymphocytopenia)
01/2024 - 01/2024
2Traumatic Brain Injuries (Traumatic Brain Injury)
11/2023 - 08/2023
2Necrosis
01/2022 - 05/2015
2Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 01/2022
2Cysts
01/2022 - 01/2019
2Fibrosis (Cirrhosis)
05/2015 - 01/2015
1Ischemic Stroke
01/2023
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2023
1Ischemia
01/2023
1Nervous System Diseases (Neurological Disorders)
02/2022
1Leukopenia
01/2022
1Spontaneous Fractures (Pathological Fracture)
01/2022
1Malnutrition (Nutritional Deficiencies)
01/2022
1Brain Injuries (Brain Injury)
10/2021
1Infarction (Infarctions)
01/2021
1Depressive Disorder (Melancholia)
12/2020
1Lymphatic Metastasis
09/2020
1Prostatic Neoplasms (Prostate Cancer)
11/2019
1Experimental Melanoma
11/2019
1Poliomyelitis (Polio)
12/2018

Drug/Important Bio-Agent (IBA)

6AntigensIBA
01/2024 - 03/2009
6AntibodiesIBA
01/2018 - 06/2003
5Proteins (Proteins, Gene)FDA Link
08/2023 - 06/2002
5Monoclonal AntibodiesIBA
05/2015 - 03/2009
4Contrast MediaIBA
02/2022 - 01/2012
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 05/2013
3VaccinesIBA
01/2024 - 09/2014
3Biomarkers (Surrogate Marker)IBA
01/2024 - 09/2014
3MicroRNAs (MicroRNA)IBA
11/2023 - 06/2012
3Therapeutic UsesIBA
11/2023 - 11/2019
3ferric oxide (iron oxide)IBA
01/2023 - 12/2018
3Liposomes (Liposome)IBA
10/2021 - 11/2016
3Temozolomide (Temodar)FDA LinkGeneric
11/2019 - 01/2016
3Cisplatin (Platino)FDA LinkGeneric
11/2016 - 10/2013
3Connexin 43 (Connexin43)IBA
05/2015 - 07/2011
2Membrane Proteins (Integral Membrane Proteins)IBA
01/2024 - 05/2015
2EnzymesIBA
03/2021 - 09/2014
2adenovirus receptorIBA
01/2021 - 01/2018
2Peptides (Polypeptides)IBA
12/2018 - 01/2016
2polyethylene glycol polyethyleneimine nanogelIBA
05/2015 - 10/2013
2NanogelsIBA
05/2015 - 10/2013
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2024
1Immune Checkpoint InhibitorsIBA
01/2024
1CytokinesIBA
01/2024
1SteroidsIBA
01/2024
1Neuroprotective AgentsIBA
11/2023
1Protein Isoforms (Isoforms)IBA
08/2023
1GadoliniumIBA
02/2022
1AlbuminsIBA
01/2022
1Alanine Transaminase (SGPT)IBA
01/2022
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022
1Alkaline PhosphataseIBA
01/2022
1BilirubinIBA
01/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2022
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022
1Methotrexate (Mexate)FDA LinkGeneric
01/2022
1CreatinineIBA
01/2022
1resazurinIBA
01/2022
1ProdrugsIBA
10/2021
1PotassiumIBA
10/2021
1liposomal doxorubicin (Doxil)FDA Link
10/2021
1Cysteine (L-Cysteine)FDA Link
01/2021
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2021
1Sulfhydryl Compounds (Thiols)IBA
01/2021
1Progesterone Receptors (Progesterone Receptor)IBA
09/2020
1Estrogen ReceptorsIBA
09/2020
1Phenobarbital (Luminal)FDA Link
08/2020
1Carcinoembryonic AntigenIBA
07/2019
1EpitopesIBA
12/2018
1transporter associated with antigen processing (TAP)IBA
12/2018
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2018
1vocimagene amiretrorepvecIBA
12/2018
1Flucytosine (Ancobon)FDA Link
12/2018
1IntegrinsIBA
01/2018

Therapy/Procedure

22Therapeutics
01/2024 - 03/2009
6Transplantation
01/2023 - 01/2016
5Oncolytic Virotherapy
01/2024 - 12/2018
4Immunotherapy
01/2024 - 09/2017
4Drug Therapy (Chemotherapy)
08/2023 - 03/2021
3Cell- and Tissue-Based Therapy (Cell Therapy)
01/2023 - 01/2021
2Aftercare (After-Treatment)
07/2022 - 12/2018
2Intravenous Injections
07/2022 - 01/2018
2Cell Transplantation
02/2022 - 01/2019
2Radiotherapy
11/2019 - 06/2012
1Chemoradiotherapy
01/2024
1Prostheses and Implants (Prosthesis)
08/2023
1Intramedullary Fracture Fixation
08/2023
1Operative Surgical Procedures
08/2023
1Nutritional Support (Artificial Feeding)
01/2022
1Stem Cell Transplantation
01/2021